© Koninklijke Brill NV, Leiden, 2009 DOI: 10.1163/157180909X437132 European Journal of Health Law 16 (2009) 173-183 brill.nl/ejhl News and Views Ovarian Tissue Cryopreservation: Promises and Uncertainties Els Olsthoorn-Heim a and Guido de Wert b a Expert in Health Law, Met Recht, Amsterdam, Th e Netherlands, E-mail: firstname.lastname@example.org b Professor of Biomedical Ethics, Faculty of Health, Medicine and Life Sciences, Dept. of Health, Ethics & Society, Maastricht University, Research Institute GROW, Th e Netherlands, E-mail: g.dewert@HES.unimaas.nl Abstract Cancer in children and young adults is increasingly being cured by operations, radiotherapy and/or che- motherapy. However, one of the serious side eﬀ ects of these treatments is the risk of damage to fertility. Whereas the most important goal used to be survival, now increasing attention is being paid to the qual- ity of life in the long term, thanks to the success of these treatments. Infertility aﬀ ects the quality of life. In post-pubescent boys and men semen can be frozen for later use prior to treatment that harms the spermatogenesis. In girls and young women the solution for reduced fertility or infertility after ovary damaging treatment, may consist of the cryopreservation of ovarian tissue prior to this treatment. At a
European Journal of Health Law – Brill
Published: Jan 1, 2009
Keywords: NORMATIVE FRAMEWORK; MEDICAL RESEARCH; INFORMED CONSENT; INFERTILITY; CANCER; OVARIAN TISSUE CRYOPRESERVATION
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera